Business Context and Reporting Period
Company: Aprea Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 9, 2026
Event: The company updated its corporate presentation slide deck, filed as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the update of corporate presentation materials and does not contain financial statements or performance data.
Material Changes
No material financial changes or operational updates are detailed in this filing. The only reported event is the dissemination of an updated corporate presentation.
Guidance, Outlook, and Risks
The filing does not contain specific guidance, outlook, management commentary, risks, contingencies, or unusual items. Investors are directed to the attached corporate presentation (Exhibit 99.1) for further details on the company's strategy and outlook.
Investor Verification Checklist
- Review the attached Corporate Presentation (Exhibit 99.1) for updated strategic information.
- Verify the trading symbol (APRE) on The Nasdaq Stock Market LLC.
- Confirm that no other material events were omitted from this specific 8-K filing.